Asset Type: Brochures, Discovery, Preclinical Imaging, Radiopharmaceutical 
Therapy & Theranostics

Preclinical Imaging Services to Advance Drug Discovery and Development

Preclinical Imaging Services to Advance Drug Discovery and Development

Gain quantitative insights into biodistribution, target engagement, and therapeutic response.

Preclinical imaging enables researchers to characterize therapeutic candidates, understand biological mechanisms, and evaluate treatment response before advancing into clinical development. Combining advanced imaging technologies with disease models and quantitative analysis provides critical insights into candidate performance.

Perceptive Discovery offers comprehensive preclinical imaging services supported by expertise in radiochemistry, in vivo and in vitro research, and imaging analytics. Our integrated approach supports therapeutic development across oncology, CNS, radiopharmaceuticals, and emerging treatment modalities.

What You’ll Learn

Download our Preclinical Imaging Services flyer to explore:

  • Multimodal imaging capabilities: PET, SPECT, MRI, CT, ultrasound, optical imaging, and cryofluorescence tomography.
  • Biodistribution and target engagement: Quantitative assessment of therapeutic localization, receptor occupancy, and tissue distribution.
  • Efficacy and pharmacodynamic biomarkers: Noninvasive imaging approaches to measure therapeutic response and support candidate selection.
  • Integrated preclinical research: In vivo, in vitro, and ex vivo capabilities across multiple disease models.
  • Radiopharmaceutical and theranostic development: Radiolabeling, diagnostic imaging, and therapeutic evaluation using alpha- and beta-emitting radionuclides.

Learn how advanced imaging and quantitative analysis can help researchers generate the evidence needed to inform drug development decisions.

Logo

Preclinical Imaging for Radioligand Therapy Development

Quantitative imaging is an important tool for evaluating radioligand therapy candidates, from confirming target localization and biodistribution to assessing therapeutic response. Perceptive Discovery integrates imaging with radiochemistry, biological assays, efficacy studies, and dosimetry to support radiopharmaceutical development.